[1] |
Kui Guoju, Huang Jiangbin, Zhang Wenhua, Yang Limin.
Effect of regional lymph node diameter on postoperative recurrence in pancreatic cancer patients
[J]. Journal of International Oncology, 2023, 50(10): 608-613.
|
[2] |
Yan Zhiying, Mao Yifeng, Zhu Yingwei, Xu Kequn.
Role of heterogeneity of cancer-associated fibroblasts in targeted therapy of pancreatic cancer
[J]. Journal of International Oncology, 2021, 48(5): 308-312.
|
[3] |
Zhong Yang, He Miao, Liu Zhi, Chen Jianyu, Zhang Guangnian, Qin Long, Li Ting, Li Jianshui.
Effects of Ophiopogon D combined with cyclooxygenase-2 silencing on proliferation, migration and invasion of human pancreatic cancer BxPC-3 cells
[J]. Journal of International Oncology, 2021, 48(10): 583-590.
|
[4] |
Li Keke, Kong Panpan, Yi Chao, Wang Xiyan, Yan Dong.
Expression of lymphoid enhancer factor-1 in pancreatic ductal adenocarcinoma and its effect on prognosis
[J]. Journal of International Oncology, 2021, 48(10): 608-613.
|
[5] |
Chen Xiaoxu, Yu Yang, Zhang Tianxue.
A prognostic risk assessment model for pancreatic cancer established based on immune-related lncRNAs
[J]. Journal of International Oncology, 2020, 47(8): 472-479.
|
[6] |
Tian Chunfang, Sha Dan.
Zinc finger proteins and digestive system cancers
[J]. Journal of International Oncology, 2020, 47(2): 115-118.
|
[7] |
Ji Zhouxin, He De.
Microbiota and pancreatic cancer
[J]. Journal of International Oncology, 2020, 47(1): 46-50.
|
[8] |
Li Qinghe, Liu Huichun, Zhang Jiayao, Li Wei.
Study on the molecular mechanism of miR-200b-3p regulates the proliferation, invasion, migration and apoptosis of pancreatic cancer cells by down-regulating VEGFA
[J]. Journal of International Oncology, 2019, 46(11): 649-656.
|
[9] |
Li Zhi, Xu Jingkai, Zhang Bo.
Mechanisms of long non-coding RNAs in tumors
[J]. Journal of International Oncology, 2018, 45(4): 220-222.
|
[10] |
Li Zhijian, He De.
Research progress on liquid biopsy in pancreatic cancer
[J]. Journal of International Oncology, 2018, 45(3): 180-182.
|
[11] |
Liang Biyu, He Weiming, He Xiaoyi, Ding Yuanlin, Yu Haibing.
Diabetes, hypoglycemic drugs and pancreatic cancer
[J]. Journal of International Oncology, 2018, 45(3): 183-186.
|
[12] |
Chen Luojun, Li Na, Tian Jingyuan, Xu Bin, Song Qibin.
Analysis of prognosis factors in nonfunctional pancreatic neuroendocrine carcinoma
[J]. Journal of International Oncology, 2018, 45(12): 721-726.
|
[13] |
WANG Yun-Liang, LI Cui.
Prognostic significance of HMGA1 and HMGA2 proteins expressions in pancreatic carcinoma
[J]. Journal of International Oncology, 2017, 44(5): 346-350.
|
[14] |
Qiao Yinbiao, Yang Bo.
Research progress of HGF/c-MET signaling pathway inhibitors in antipancreatic cancer
[J]. Journal of International Oncology, 2017, 44(4): 304-306.
|
[15] |
于兰,张小涛,李进英,王玉.
Clinical application of FOLFIRINOX regimen for pancreatic cancer
[J]. Journal of International Oncology, 2017, 44(11): 874-878.
|